Index of /wp-content/uploads/2024/12

[ICO]NameLast modifiedSizeDescription
[PARENTDIR]Parent Directory  -  
[ ]Advisory-HTA-Guidance-Document-for-the-use-of-Real-World-Evidence-11-December-2024.docx-1.pdf2024-12-11 14:37 295K 
[ ]Advisory-HTA-Guidance-Document-for-the-use-of-Real-World-Evidence-11-December-2024.docx.pdf2024-12-11 11:42 295K 
[ ]Advisory-Philippine-Guidance-Document-for-the-use-of-Real-World-Evidence-11-December-2024.docx.pdf2024-12-11 11:44 295K 
[ ]Batch-4-Call-Guide-Call-for-Proposals-Guidelines-Cycle-2-Clinical-and-FEC_Cycle-1-EE_ELSHI-Topics.pdf2024-12-19 10:19 300K 
[ ]CEA-for-Ivabradine-HF-Final_EE_TOR_2024-Batch-3.pdf2024-12-19 09:08 217K 
[ ]CEA-for-MERVO-Final_EE_TOR_2024-Batch-3.pdf2024-12-19 09:08 212K 
[ ]CEA-for-Tirofiban-CIS-Final_EE_TOR_2024-Batch-4.pdf2024-12-19 09:35 234K 
[ ]CEA-for-Tirofiban-NSTE-ACS-Final_EE_TOR_2024-Batch-4.pdf2024-12-19 09:35 234K 
[ ]CMA-for-PP3M-Final_EE_TOR_2024-Batch-4.pdf2024-12-19 09:35 224K 
[ ]CMA-for-wAMD-Final_EE_TOR_2024-Batch-3.pdf2024-12-19 09:09 205K 
[ ]CUA-for-RAA-T1DM-Final_EE_TOR_2024-Batch-3.pdf2024-12-19 09:09 214K 
[ ]CUA-for-RAA-T2DM-Final_EE_TOR_2024-Batch-3.pdf2024-12-19 09:09 213K 
[ ]CUA-for-Ticagrelor-TE-Final_EE_TOR_2024-Batch-3.pdf2024-12-19 09:09 215K 
[ ]Cycle-2-Gen-Track-Clinical-TOR_2024-Batch-4.pdf2024-12-19 10:18 229K 
[ ]Cycle-2-Gen-Track-Clinical_TOR_2024-Batch-4.pdf2024-12-19 09:35 229K 
[ ]DOH-Department-Circular-2022-0289-SOH-Decision-on-Tocilizumab-for-treatment-of-COVID-19-16-May-2022_1.pdf2024-12-19 05:20 9.8M 
[ ]ELSHI-Standard-TOR-Final_ELSHI_TOR_2024-Batch-3.pdf2024-12-19 09:08 213K 
[ ]FOR-REPOSTING-Batch-3-Call-Guide-Proposal-Guidelines-for-EE_ELSHI-Topics_19Dec2024-1.pdf2024-12-19 10:45 373K 
[ ]FOR-REPOSTING-Batch-3-Call-Guide-Proposal-Guidelines-for-EE_ELSHI-Topics_19Dec2024.pdf2024-12-19 10:37 373K 
[ ]For-Posting-Batch-3-Call-for-Proposal-Guidelines_EE_ELSHI-Topics.pdf2024-12-19 09:02 373K 
[ ]For-Posting-Batch-4-Call-for-Proposals-Guidelines_EE_ELSHI_Clinical-Assessment-Topics.pdf2024-12-19 09:34 300K 
[ ]For-Public-Consultation-HTA-Methods-Guide-for-the-use-of-Real-World-Evidence-PDF-1-1.pdf2024-12-11 14:33 1.5M 
[ ]For-Public-Consultation-HTA-Methods-Guide-for-the-use-of-Real-World-Evidence-PDF-1.pdf2024-12-11 11:42 1.4M 
[ ]For-Public-Consultation-HTA-Methods-Guide-for-the-use-of-Real-World-Evidence-PDF-2.pdf2024-12-12 12:02 1.5M 
[ ]For-Public-Consultation-HTA-Methods-Guide-for-the-use-of-Real-World-Evidence-PDF-3.pdf2024-12-12 12:05 1.5M 
[ ]For-Public-Consultation-HTA-Methods-Guide-for-the-use-of-Real-World-Evidence-PDF.pdf2024-12-11 11:56 1.4M 
[ ]For-Public-Consultation-Philippine-Guidance-Document-for-the-use-of-Real-World-Evidence-for-Clinical-Assessment.pdf2024-12-11 11:44 1.4M 
[ ]HTAC-Approved-as-of-07-Apr-2022-SAAgT-Evidence-Summary.docx-1.pdf2024-12-17 17:28 1.3M 
[ ]HTAC-Approved-as-of-07-Apr-2022-SAAgT-Evidence-Summary.docx.pdf2024-12-17 17:27 1.3M 
[ ]HTAC-Approved-as-of-07-Apr-2022-SAAgT-Evidence-Summary.pdf2024-12-17 17:29 1.3M 
[ ]Model-based-CMA-for-DPP4-i-Final_EE_TOR_2024-Batch-3.pdf2024-12-19 09:10 209K 
[ ]Signed-by-OSEC-HTAC-Recommendations-on-COVID-19-Investigational-Drugs1.pdf2024-12-19 05:29 3.0M 
[IMG]WEBSITE_HTAD-Copy-of-Announcement-posters-6-150x150.jpg2024-12-19 10:55 8.0K 
[IMG]WEBSITE_HTAD-Copy-of-Announcement-posters-6-150x150.png2024-12-11 11:53 18K 
[IMG]WEBSITE_HTAD-Copy-of-Announcement-posters-6-300x114.jpg2024-12-19 10:55 13K 
[IMG]WEBSITE_HTAD-Copy-of-Announcement-posters-6-300x114.png2024-12-11 11:53 26K 
[IMG]WEBSITE_HTAD-Copy-of-Announcement-posters-6-500x190.jpg2024-12-19 10:55 27K 
[IMG]WEBSITE_HTAD-Copy-of-Announcement-posters-6-500x190.png2024-12-11 11:53 69K 
[IMG]WEBSITE_HTAD-Copy-of-Announcement-posters-6-768x293.jpg2024-12-19 10:55 48K 
[IMG]WEBSITE_HTAD-Copy-of-Announcement-posters-6-768x293.png2024-12-11 11:53 137K 
[IMG]WEBSITE_HTAD-Copy-of-Announcement-posters-6-1024x390.jpg2024-12-19 10:55 68K 
[IMG]WEBSITE_HTAD-Copy-of-Announcement-posters-6-1024x390.png2024-12-11 11:53 246K 
[IMG]WEBSITE_HTAD-Copy-of-Announcement-posters-6.jpg2024-12-19 10:55 66K 
[IMG]WEBSITE_HTAD-Copy-of-Announcement-posters-6.png2024-12-11 11:53 79K 
[IMG]WEBSITE_HTAD-Copy-of-Announcement-posters-7-150x150.jpg2024-12-19 10:55 8.1K 
[IMG]WEBSITE_HTAD-Copy-of-Announcement-posters-7-150x150.png2024-12-11 14:39 18K 
[IMG]WEBSITE_HTAD-Copy-of-Announcement-posters-7-300x114.jpg2024-12-19 10:55 13K 
[IMG]WEBSITE_HTAD-Copy-of-Announcement-posters-7-300x114.png2024-12-11 14:39 26K 
[IMG]WEBSITE_HTAD-Copy-of-Announcement-posters-7-500x190.jpg2024-12-19 10:55 27K 
[IMG]WEBSITE_HTAD-Copy-of-Announcement-posters-7-500x190.png2024-12-11 14:39 68K 
[IMG]WEBSITE_HTAD-Copy-of-Announcement-posters-7-768x293.jpg2024-12-19 10:55 49K 
[IMG]WEBSITE_HTAD-Copy-of-Announcement-posters-7-768x293.png2024-12-11 14:39 137K 
[IMG]WEBSITE_HTAD-Copy-of-Announcement-posters-7-1024x390.jpg2024-12-19 10:55 71K 
[IMG]WEBSITE_HTAD-Copy-of-Announcement-posters-7-1024x390.png2024-12-11 14:39 246K 
[IMG]WEBSITE_HTAD-Copy-of-Announcement-posters-7.jpg2024-12-19 10:55 69K 
[IMG]WEBSITE_HTAD-Copy-of-Announcement-posters-7.png2024-12-11 14:39 79K 
[IMG]WEBSITE_HTAD-Copy-of-Announcement-posters-8-150x150.jpg2024-12-19 11:14 7.9K 
[IMG]WEBSITE_HTAD-Copy-of-Announcement-posters-8-300x114.jpg2024-12-19 11:14 13K 
[IMG]WEBSITE_HTAD-Copy-of-Announcement-posters-8-500x190.jpg2024-12-19 11:14 27K 
[IMG]WEBSITE_HTAD-Copy-of-Announcement-posters-8-768x293.jpg2024-12-19 11:14 49K 
[IMG]WEBSITE_HTAD-Copy-of-Announcement-posters-8-1024x390.jpg2024-12-19 11:14 71K 
[IMG]WEBSITE_HTAD-Copy-of-Announcement-posters-8.jpg2024-12-19 11:14 69K 
[IMG]WEBSITE_HTAD-Copy-of-Announcement-posters-9-150x150.jpg2024-12-19 11:14 8.0K 
[IMG]WEBSITE_HTAD-Copy-of-Announcement-posters-9-300x114.jpg2024-12-19 11:13 13K 
[IMG]WEBSITE_HTAD-Copy-of-Announcement-posters-9-500x190.jpg2024-12-19 11:14 27K 
[IMG]WEBSITE_HTAD-Copy-of-Announcement-posters-9-768x293.jpg2024-12-19 11:14 48K 
[IMG]WEBSITE_HTAD-Copy-of-Announcement-posters-9-1024x390.jpg2024-12-19 11:14 68K 
[IMG]WEBSITE_HTAD-Copy-of-Announcement-posters-9.jpg2024-12-19 11:13 66K 
Apache/2.4.29 (Ubuntu) Server at hta.dost.gov.ph Port 443